Ratings and dated fundamentals
Exact eligible report scores in ranking order. Ratings summarize dated reports, not future returns; report and market dates remain in the table. Showing the first 10 of 93 recorded values; the complete table remains available below.
See the complete ratings and dated fundamentals
Scroll sideways to compare all columns. Select a heading to sort.
| 1 | iRadimed Corporation | IRMD | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.31 | $1,103,745,485.43 | 46.02 | 10.37 |
| 2 | Boston Scientific Corp. | BSX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.75 | $61,964,980,240.5 | 17.73 | Not reported |
| 3 | CONMED Corporation | CNMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $51.5 | $1,534,871,134.5 | 20.9 | 1.45 |
| 4 | Electromed, Inc. | ELMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.17 | $227,308,648.71 | 20.11 | 4.21 |
| 5 | InMode Ltd. Ordinary Shares | INMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.33 | $767,063,812.76 | 8.17 | 1.12 |
| 6 | LeMaitre Vascular, Inc. | LMAT | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $80.89 | $1,850,833,655.19 | 29.22 | 4.28 |
| 7 | Merit Medical Systems Inc | MMSI | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $87.23 | $5,226,389,288.12 | 32.64 | 3 |
| 8 | Veracyte, Inc. | VCYT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.16 | $1,949,602,796.8 | 15.37 | 1.36 |
| 9 | Inspire Medical Systems, Inc. | INSP | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.98 | $1,853,252,293.62 | 18.4 | 2.24 |
| 10 | Utah Medical Products Inc | UTMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.23 | $229,967,174.14 | 21.93 | 1.88 |
| 11 | Viemed Healthcare, Inc. Common Shares | VMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.13 | $345,963,948.22 | 22.14 | 2.28 |
| 12 | Artivion, Inc. | AORT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.21 | $986,041,292.12 | Not reported | 2.21 |
| 13 | AtriCure, Inc. | ATRC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $58.54 | $2,980,990,446.82 | 200.29 | 5.59 |
| 14 | Axogen, Inc. Common Stock | AXGN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $50.02 | $2,987,730,364.3 | Not reported | 6.02 |
| 15 | Baird Medical Investment Holdings Ltd Ordinary Share | BDMD | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.09 | $2,825,894.72 | Not reported | 0.09 |
| 16 | Bioventus Inc. Class A Common Stock | BVS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.61 | $892,214,846.8 | 15.57 | 3.06 |
| 17 | Delcath Systems Inc | DCTH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.93 | $518,053,009.35 | 973.78 | 4.28 |
| 18 | Embecta Corp. Common Stock | EMBC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.19 | $350,722,917.81 | 4.01 | Not reported |
| 19 | NeoGenomics, Inc. | NEO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.84 | $2,178,918,590.6 | Not reported | 2.72 |
| 20 | Anbio Biotechnology Class A Ordinary Shares | NNNN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.89 | $170,736,768 | 26.66 | 5.66 |
| 21 | Neuropace, Inc. Common Stock | NPCE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $12.5 | $429,053,425 | Not reported | 36.11 |
| 22 | Precipio, Inc. Common Stock | PRPO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $18.62 | $33,333,300.56 | Not reported | 2.26 |
| 23 | SI-BONE, Inc. Common Stock | SIBN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.24 | $1,093,541,228.88 | Not reported | 5.92 |
| 24 | SANUWAVE Health, Inc. Common Stock | SNWV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $18,839,056.71 | 1.32 | 6.76 |
| 25 | Sensus Healthcare, Inc | SRTS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.86 | $47,081,488.74 | Not reported | 1.28 |
| 26 | Staar Surgical Co | STAA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.21 | $1,265,587,856.99 | 2,387.9 | 3.36 |
| 27 | Xtant Medical Holdings, Inc. | XTNT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.29 | $40,599,335.62 | Not reported | 1.01 |
| 28 | AETHLON MEDICAL INC | AEMD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.47 | $3,889,913.92 | Not reported | Not reported |
| 29 | AngioDynamics, Inc. | ANGO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.73 | $493,298,698.5 | Not reported | 3.01 |
| 30 | Anika Therapeutics Inc | ANIK | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.55 | $194,901,804.15 | Not reported | Not reported |
| 31 | Accuray Incorporated | ARAY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.11 | $13,138,323.77 | Not reported | 0.32 |
| 32 | Cerus Corp | CERS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.02 | $407,947,451.68 | Not reported | 5.34 |
| 33 | CVRx, Inc. Common Stock | CVRX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.87 | $24,744,936.01 | Not reported | 1.79 |
| 34 | Guardant Health, Inc. Common Stock | GH | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $150.87 | $20,410,595,048.25 | Not reported | Not reported |
| 35 | GRAIL, Inc. Common Stock | GRAL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $121.44 | $5,460,206,046.24 | Not reported | 2.23 |
| 36 | OrthoPediatrics Corp. Common Stock | KIDS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.76 | $829,268,717.76 | Not reported | 2.44 |
| 37 | KORU Medical Systems, Inc. Common Stock (DE) | KRMD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.09 | $142,671,177.18 | Not reported | 7.9 |
| 38 | Pulmonx Corporation Common Stock | LUNG | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.56 | $111,489,702.4 | Not reported | 3.26 |
| 39 | Myomo Inc. | MYO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.21 | $47,925,503.34 | Not reported | 8.22 |
| 40 | InspireMD, Inc. | NSPR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.7 | $32,356,426.13 | Not reported | 1.03 |
| 41 | NovoCure Limited Ordinary Shares | NVCR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.28 | $1,552,643,935.52 | Not reported | 4.43 |
| 42 | OraSure Technologies Inc | OSUR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.44 | $237,252,076.88 | Not reported | 0.75 |
| 43 | Pulse Biosciences, Inc Common Stock (DE) | PLSE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $53.29 | $3,919,422,159.96 | Not reported | 21.35 |
| 44 | Profound Medical Corp. Common Stock | PROF | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.21 | $264,079,545.24 | Not reported | 6.21 |
| 45 | Personalis, Inc. Common Stock | PSNL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.79 | $1,711,696,223.06 | Not reported | 8.05 |
| 46 | RenovoRx, Inc. Common Stock | RNXT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.13 | $54,523,168.96 | Not reported | 5.87 |
| 47 | Sight Sciences, Inc. Common Stock | SGHT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.08 | $560,236,088.16 | Not reported | 11.4 |
| 48 | Sanara MedTech Inc. Common Stock | SMTI | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.55 | $289,882,504.25 | Not reported | 36.53 |
| 49 | Neuronetics, Inc. Common Stock | STIM | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.15 | $167,115,868.65 | Not reported | 7.46 |
| 50 | TELA Bio, Inc. Common Stock | TELA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.82 | $36,813,700.74 | Not reported | Not reported |
| 51 | Tempus AI, Inc. Class A Common Stock | TEM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $76.05 | $13,338,483,040.35 | Not reported | 26.66 |
| 52 | Exagen Inc. Common Stock | XGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.81 | $140,749,219.59 | Not reported | 11.52 |
| 53 | Autonomix Medical, Inc. Common Stock | AMIX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.52 | $1,475,985.36 | Not reported | 0.47 |
| 54 | Bone Biologics Corp Common Stock | BBLG | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.33 | $1,129,911.6 | Not reported | 0.19 |
| 55 | Biodesix, Inc. Common Stock | BDSX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.53 | $94,584,998.83 | Not reported | 10.9 |
| 56 | Bluejay Diagnostics, Inc. Common Stock | BJDX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.35 | $1,165,414.35 | Not reported | 0.12 |
| 57 | BIOMERICA INC | BMRA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.61 | $7,404,338.48 | Not reported | 2.03 |
| 58 | Burning Rock Biotech Limited American Depositary Shares | BNR | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.42 | $874,860.54 | Not reported | 0.01 |
| 59 | Concord Medical Services Holding Limited | CCM | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.71 | $16,107,791.71 | Not reported | 0.06 |
| 60 | ClearPoint Neuro, Inc. Common Stock | CLPT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.6 | $275,666,704.8 | Not reported | 10.11 |
| 61 | Cytosorbents Corp. | CTSO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.8 | $15,082,257.6 | Not reported | Not reported |
| 62 | Alpha Tau Medical Ltd. Ordinary Shares | DRTS | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.72 | $1,268,800,272.88 | Not reported | 16.46 |
| 63 | Elutia Inc. Class A Common Stock | ELUT | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.84 | $37,087,801.2 | 0.72 | 2.36 |
| 64 | Establishment Labs Holdings Inc. | ESTA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $67.02 | $1,997,322,734.82 | Not reported | 92.44 |
| 65 | Femasys Inc. Common Stock | FEMY | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.37 | $4,142,834.79 | Not reported | 1.03 |
| 66 | Vyome Holdings, Inc. Common Stock | HIND | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.58 | $11,089,274.24 | Not reported | 1.52 |
| 67 | IceCure Medical Ltd. Ordinary Shares | ICCM | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.68 | $3,157,345.95 | Not reported | 0.35 |
| 68 | MDxHealth SA Ordinary Shares | MDXH | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.16 | $14,980,528.97 | Not reported | Not reported |
| 69 | NeuroOne Medical Technologies Corporation Common Stock | NMTC | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.88 | $8,003,965.68 | Not reported | 2.12 |
| 70 | Neuraxis, Inc. | NRXS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.24 | $78,360,453.6 | Not reported | 11.63 |
| 71 | Nuwellis, Inc. Common Stock | NUWE | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.58 | $292,332.24 | Not reported | Not reported |
| 72 | enVVeno Medical Corporation Common Stock | NVNO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.73 | $4,676,178.98 | Not reported | 0.28 |
| 73 | Nexalin Technology, Inc. Common Stock | NXL | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.47 | $1,079,784.09 | Not reported | 0.71 |
| 74 | Orchestra BioMed Holdings, Inc. Ordinary Shares | OBIO | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.68 | $341,396,678.32 | Not reported | 11.6 |
| 75 | Polyrizon Ltd. Ordinary Shares | PLRZ | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $11.05 | $26,823,931.18 | Not reported | Not reported |
| 76 | Avita Medical, Inc. Common Stock | RCEL | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.59 | $518,730,571.45 | Not reported | Not reported |
| 77 | Retractable Technologies, Inc | RVP | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.57 | $16,926,469.7 | Not reported | 0.23 |
| 78 | Senseonics Holdings, Inc. Common Stock | SENS | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.59 | $454,188,115.27 | Not reported | 5.03 |
| 79 | Sera Prognostics, Inc. Class A Common Stock | SERA | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $86,394,330.54 | Not reported | 1.65 |
| 80 | Streamex Corp. Common Stock | STEX | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.34 | $39,481,776.36 | Not reported | 0.27 |
| 81 | TriSalus Life Sciences, Inc. Common Stock | TLSI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.25 | $200,117,450 | Not reported | 30.55 |
| 82 | Treace Medical Concepts, Inc. Common Stock | TMCI | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.03 | $264,205,175.91 | Not reported | 4.29 |
| 83 | Tenon Medical, Inc. Common Stock | TNON | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.64 | $15,494.72 | Not reported | Not reported |
| 84 | Virax Biolabs Group Limited Ordinary Shares | VRAX | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.79 | $1,065,096 | Not reported | 0.15 |
| 85 | WORK Medical Technology Group LTD Class A Ordinary Shares | WOK | 1.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.95 | $4,223,648.24 | Not reported | 0.2 |
| 86 | Beyond Air, Inc. Common Stock | XAIR | 1.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.16 | $2,068,482.96 | Not reported | 0.73 |
| 87 | Adagio Medical Holdings, Inc Common Stock | ADGM | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.06 | $1,441,458.79 | Not reported | Not reported |
| 88 | Advanced Biomed Inc. Common Stock | ADVB | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.98 | $3,271,223.34 | 0.49 | 0.27 |
| 89 | Anteris Technologies Global Corp. Common Stock | AVR | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.69 | $554,538,717.06 | Not reported | 2.2 |
| 90 | Envoy Medical, Inc. Class A Common Stock | COCH | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.15 | $55,373,089.2 | Not reported | Not reported |
| 91 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | CUPR | 1 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.8 | $12,606,764.4 | Not reported | 3.21 |
| 92 | Solana Company Class A Common Stock (DE) | HSDT | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.93 | $116,685,296.79 | Not reported | 0.69 |
| 93 | ENDRA Life Sciences Inc. Common Stock | NDRA | 1 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.73 | $7,094,233.74 | Not reported | 1.12 |
No matching rows. Clear the filter to see all records.
93 companies with eligible ratings and dated fundamentals, from 94 eligible companies in this selection.
Inspect a rated peer
Ratings and dated fundamentals
Onconetix, Inc. Common Stock (ONCO): source evidence dated 2026-11-07T12:42:51.530Z.
- Rank
- 1
- Company
- iRadimed Corporation
- Ticker
- IRMD
- Rating / 5
- 4
- Report date
- 2025-12-31
- Fiscal period
- 2025 FY
- Model
- anthropic/claude-haiku-5-5
- Market day
- 2026-11-06
The selected ticker, rating, report date and producing model match the first displayed row. Equal ratings use ticker order.
Which recorded peer has the highest usable rating?
The provider's peer set defines membership. It does not establish identical risk or business models. Read report dates and producing models.
NexusTrade stock ratings and report filters- Median market capitalization
- $142,671,177.18 · 93 / 93 displayed companies
- Median positive P/E (TTM)
- 20.51 · 20 / 93 displayed companies
- Median positive price / book
- 2.44 · 79 / 93 displayed companies
- Largest company by market cap
- Boston Scientific Corp. (BSX) · $61,964,980,240.5
- Largest company's share of displayed market cap
- 41.86% · Sum of displayed market caps; not portfolio weights or revenue exposure
Check each median’s included count and each company’s market date. These are unweighted summaries of displayed companies, not a sector index or revenue exposure.
Research ONCO
Open a peer's company view and compare how it actually earns revenue with the anchor company.
Research ONCOKeep reporting dates and units beside the answer, and inspect its original citations.
How these companies are related
Peer membership comes from the same related-company provider used by NexusTrade's stock research. The provider identifies related companies using news coverage and returns data. A related company can be a competitor or a thematic peer; this list does not imply identical products or financial exposure.
Peer membership was fetched 2026-10-12.
The rating determines the order after peer membership is selected. The anchor company is excluded. Companies without an eligible report rating or dated fundamentals are counted in coverage and left out of the ranked table.
What best means in this list
This list was refreshed on 2026-11-07 using existing company reports. The report date in each row is the date of the underlying analysis; refreshing the list does not create a new company report.
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
The peer set comes from the recorded related-company provider. Similarity defines which companies enter this comparison; it does not establish that they have equal business models, risk or expected returns.
What the leading companies do
The first 5 companies below lead the ratings in this snapshot; equal ratings are ordered by ticker. Their company profiles describe different businesses even when they share the Onconetix, Inc. Common Stock (ONCO) selection.
These are company descriptions, not estimates of revenue from this theme. Industry membership does not identify a pure-play business or establish how much sales depend on it. Open the company profile and examine segment disclosures before treating an overlapping classification as equivalent exposure.
iRadimed Corporation (IRMD): 4 / 5
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Boston Scientific Corp. (BSX): 3.5 / 5
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
CONMED Corporation (CNMD): 3.5 / 5
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Electromed, Inc. (ELMD): 3.5 / 5
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
InMode Ltd. Ordinary Shares (INMD): 3.5 / 5
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
Valuation and company size within this selection
These summaries use the 93 displayed companies. Each company retains its own market observation date in the ratings table above. Medians are unweighted; they are not a sector index valuation.
Positive P/E and price-to-book values are summarized separately. Missing, zero and negative values are excluded from those medians, with the included count shown. A lower multiple alone does not establish better value: profitability, growth, debt and business mix can differ.
Show the table · 5 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Median market capitalization | $142,671,177.18 | 93 / 93 displayed companies |
| Median positive P/E (TTM) | 20.51 | 20 / 93 displayed companies |
| Median positive price / book | 2.44 | 79 / 93 displayed companies |
| Largest company by market cap | Boston Scientific Corp. (BSX) | $61,964,980,240.5 |
| Largest company's share of displayed market cap | 41.86% | Sum of displayed market caps; not portfolio weights or revenue exposure |
No matching rows. Clear the filter to see all records.
Other business classifications in the list
A company can appear in several product and revenue classifications. These overlapping memberships help identify different business mixes to investigate; they are not verified revenue shares or mutually exclusive subindustries.
Show the table · 5 rows, 2 columns
| Additional classification | Matching displayed companies |
|---|---|
| Healthcare | 93 / 93 |
| Medical Devices | 91 / 93 |
| Technology | 60 / 93 |
| Hardware | 51 / 93 |
| Manufacturing | 51 / 93 |
No matching rows. Clear the filter to see all records.
Dates and coverage
Report dates range from 2025-12-31 to 2025-12-31. Market observations range from 2026-11-06 to 2026-11-06. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 0 companies without a report, 0 with invalid latest rating metadata, 0 with older reports, 1 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.